GLP-1 receptor agonists (semaglutide, liraglutide, dulaglutide) and the dual agonist tirzepatide are backed by STEP ( The New England Journal of Medicine , 2021), SURMOUNT (NEJM, 2022), and SURMOUNT-OSA (NEJM, 2024)
Accessed April 16, 2024 .] GLP-1s Past, Present and Future Given the recent craze, it may surprise some that the GLP-1 drug Saxenda ( liraglutide ) was approved by the FDA for weight reduction in people without T2D 10 years ago
If you are still deciding whether a medically supervised program makes sense, you can complete a free eligibility assessment before making any changes
This study investigated the potential association between GLP-1RAs and SSIBs by exploring the FDA Adverse Event Reporting System (FAERS) database
Take the first step today with a free consultation at Skin Works Medical Spa